McFarlane Neil F. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.8M

Insider Activity of McFarlane Neil F.

According to the SEC Form 4 filings, McFarlane Neil F., being in a position of

  1. President and CEO at Zevra Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 125625 shares for $1.2M,
    over all time since 2025-02-13, has bought 0 shares, and sold 236942 shares for $2.14M.

Biography of McFarlane Neil F.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,203,5593100

Comparison of Insiders on Amount of Buys and Sells

2026-10-12SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
20,000
0.0336%
$11.25$224,948-9.32%
2026-02-09SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
14,625
0.0259%
$8.56$125,186+25.2%
2026-02-02SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
91,000
0.162%
$9.38$853,425+13.68%
2025-10-10SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
19,500
0.0341%
$10.82$210,908-7.77%
2025-02-14SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
30,544
0.0577%
$8.05$245,962+9.17%
2025-02-13SaleZevra Therapeutics, Inc.
ZVRA
President and CEO
61,273
0.1168%
$7.86$481,428+10.26%
2019-05-16SaleTravere Therapeutics, Inc.
TVTX
Chief Operating Officer
984
0.0024%
$18.71$18,411-18.52%
2019-05-15SaleTravere Therapeutics, Inc.
TVTX
Chief Operating Officer
984
0.0022%
$17.78$17,496-18.52%
2018-12-20SaleTravere Therapeutics, Inc.
TVTX
Chief Operating Officer
22,250
0.0533%
$22.32$496,666-15.09%
2018-11-14SaleTravere Therapeutics, Inc.
TVTX
Chief Operating Officer
20,000
0.049%
$23.73$474,629-14.02%
2017-08-16SaleTravere Therapeutics, Inc.
TVTX
Chief Operating Officer
2,756
0.0069%
$22.50$62,010+5.35%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.